The HFSA Virtual Board Certification Review 2021 will be comprised of renowned heart failure experts presenting curriculum that has been tailored to the actual ABIM examination blueprint. The course will take place over three (3) days (July 16-18, 2021) and include the components outlined below. Check back soon for preliminary agenda, Advance Program, and more!

Program Components

The program will be made up of the following components to allow attendees greater access to the content.

Pre-Recorded Webinar Series: Heart Failure Fundamentals

This pre-recorded, ondemand webinar series features the basics and can be completed at the attendee's convenience. Coming soon!

Simu-Live Sessions

Three, non-consecutive days of simu-live sessions (July 16-18, 2021) delivered by top experts in the field. Live sessions will be available to download shortly after the live presentation. Coming soon!

Faculty "Office Hours"

Post-meeting, virtual livestream Q&A panel taking place in September 2021 to allow attendees to ask follow-up questions.

Intended Audience

The HFSA Virtual Board Certification Review 2020 is designed for physicians who are preparing to take the ABIM Advanced Heart Failure & Transplant Cardiology Board Maintenance of Certification Exam.

Learning Objectives

Upon completion of the activity, participants will demonstrate improved competence and ability to: 

For the Certification Examination in Advanced Heart Failure and Transplant Cardiology:

  1. Identify gaps in knowledge about advanced heart failure and transplant cardiology
  2. Focus study efforts on filling identified knowledge gaps
  3. Practice for the certification examination with ABIM-style multiple-choice test questions

For Clinical Practice:

  1. Describe the epidemiology of heart failure, including environmental factors, and implement strategies for the prevention of heart failure
  2. Describe the pathophysiology of heart failure, including normal physiology and compensatory and maladaptive mechanisms
  3. Assess and follow the patient with acute or advanced heart failure, using non-invasive and invasive tests and biomarkers.
  4. Implement guideline-based therapy for patients with chronic heart failure, including pharmacologic agents; non-pharmacologic options, such as diet and exercise; and implantable devices
  5. Implement appropriate care strategies for patients undergoing chemotherapy or with pulmonary hypertension, heart failure with preserved ejection fraction, or cardiorenal syndrome.
  6. Manage comorbidities in patients with chronic heart failure, including sleep disordered breathing, anemia, and depression
  7. Implement strategies for effective disease management of the patient with advanced heart failure, including palliative care and transition to outpatient care
  8. Provide peri-operative management of heart failure patients undergoing cardiac transplantation or implantation of a mechanical circulatory device

Concise presentations by national experts will focus on blueprint content.